UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 478

Sortiert nach

Innate immune dysfunction in inflammatory bowel disease

Journal of internal medicine, 2012-05, Vol.271 (5), p.421-428

2012

Link zum Volltext

Verfügbarkeit prüfen

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management

Journal of Crohn's & colitis, 2010-02, Vol.4 (1), p.28-62

2010

Link zum Volltext

Verfügbarkeit prüfen

Probiotic lactobacilli and VSL#3 induce enterocyte β-defensin 2

Clinical and experimental immunology, 2008-03, Vol.151 (3), p.528-535

2008

Link zum Volltext

Verfügbarkeit prüfen

European evidence based consensus on the diagnosis and management of Crohn’s disease: definitions and diagnosis

Gut, 2006-03, Vol.55 (suppl 1), p.i1-i15

2006

Link zum Volltext

Verfügbarkeit prüfen

European evidence based consensus on the diagnosis and management of Crohn’s disease: current management

Gut, 2006-03, Vol.55 (suppl 1), p.i16-i35

2006

Link zum Volltext

Verfügbarkeit prüfen

Short‐term efficacy of tacrolimus in steroid‐refractory ulcerative colitis – experience in 130 patients

Alimentary pharmacology & therapeutics, 2013-01, Vol.37 (1), p.129-136

2013

Link zum Volltext

Verfügbarkeit prüfen

NOD2 (CARD15) mutations in Crohn’s disease are associated with diminished mucosal α-defensin expression

Gut, 2004-11, Vol.53 (11), p.1658-1664

2004

Link zum Volltext

Verfügbarkeit prüfen

European evidence-based Consensus on the management of ulcerative colitis: Current management

Journal of Crohn's and colitis, 2008-03, Vol.2 (1), p.24-62

2008

Link zum Volltext

Verfügbarkeit prüfen

Infliximab as rescue medication for patients with severe ulcerative/indeterminate colitis refractory to tacrolimus

Alimentary pharmacology & therapeutics, 2010-05, Vol.31 (9), p.1036-1041

2010

Link zum Volltext

Verfügbarkeit prüfen

Long-term Outcomes in Steroid-refractory Ulcerative Colitis Treated with Tacrolimus Alone or in Combination with Purine Analogues

Journal of Crohn's and colitis, 2016-01, Vol.10 (1), p.31-37

2016

Link zum Volltext

Verfügbarkeit prüfen

Steroid-unresponsive acute attacks of inflammatory bowel disease: immunomodulation by tacrolimus (FK506)

The American journal of gastroenterology, 1998-10, Vol.93 (10), p.1860-1866

1998

Link zum Volltext

Verfügbarkeit prüfen

ABCB1 Single‐Nucleotide Polymorphisms Determine Tacrolimus Response in Patients With Ulcerative Colitis

Clinical pharmacology and therapeutics, 2011-03, Vol.89 (3), p.422-428

2011

Link zum Volltext

Verfügbarkeit prüfen

Influence of standard treatment on ileal and colonic antimicrobial defensin expression in active Crohn’s disease

Alimentary pharmacology & therapeutics, 2009-09, Vol.30 (6), p.621-633

2009

Link zum Volltext

Verfügbarkeit prüfen

Defensin pattern in chronic gastritis: HBD-2 is differentially expressed with respect to Helicobacter pylori status

Journal of clinical pathology, 2003-05, Vol.56 (5), p.352-357

2003

Link zum Volltext

Verfügbarkeit prüfen

Randomized, double blind controlled trial of subcutaneous recombinant human interleukin-11 Versus prednisolone in active crohn's disease

The American journal of gastroenterology, 2006-04, Vol.101 (4), p.793-797

2006

Link zum Volltext

Verfügbarkeit prüfen

European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease

Journal of Crohn's and colitis, 2009-06, Vol.3 (2), p.47-91

2009

Link zum Volltext

Verfügbarkeit prüfen

European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis

Journal of Crohn's and colitis, 2008-03, Vol.2 (1), p.1-23

2008

Link zum Volltext

Verfügbarkeit prüfen

Paneth cell α-defensin 6 (HD-6) is an antimicrobial peptide

Mucosal immunology, 2015-05, Vol.8 (3), p.661-671

2015

Link zum Volltext

Verfügbarkeit prüfen

Decreased Paneth cell defensin expression in ileal Crohn’s disease is independent of inflammation, but linked to the NOD2 1007fs genotype

Gut, 2009-06, Vol.58 (6), p.882-3; discussion 883-4

2009

Link zum Volltext

Verfügbarkeit prüfen

6‐Thioguanine — efficacy and safety in chronic active Crohn's disease

Alimentary pharmacology & therapeutics, 2003-02, Vol.17 (4), p.503-508

2003

Link zum Volltext

Verfügbarkeit prüfen

Barrier dysfunction due to distinct defensin deficiencies in small intestinal and colonic Crohn's disease

Mucosal immunology, 2008-11, Vol.1 (1s), p.S67-S74

2008

Link zum Volltext

Verfügbarkeit prüfen

Synergistic Sedation with Low-Dose Midazolam and Propofol for Colonoscopies

Endoscopy, 2000-03, Vol.32 (3), p.239-244

2000

Link zum Volltext

Verfügbarkeit prüfen

Alterations in pulmonary function in inflammatory bowel disease are frequent and persist during remission

The American journal of gastroenterology, 2002-02, Vol.97 (2), p.377-381

2002

Link zum Volltext

Verfügbarkeit prüfen

Mycophenolate mofetil: lack of efficacy in chronic active inflammatory bowel disease

Alimentary pharmacology & therapeutics, 2000-02, Vol.14 (2), p.171-176

2000

Link zum Volltext

Verfügbarkeit prüfen

Innate immunity and colonic inflammation: Enhanced expression of epithelial α-defensins

Digestive diseases and sciences, 2002-06, Vol.47 (6), p.1349-1355

2002

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 478

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(396)
Mit Volltextzugriff
(391)

Publikationsform

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(264)
Humans
(248)
Life Sciences & Biomedicine
(241)
Gastroenterology & Hepatology
(116)
Biological And Medical Sciences
(110)
Male
(107)
Female
(93)
Medical Sciences
(83)
Adult
(82)
Animals
(65)
Middle Aged
(64)
Aged
(45)
Gastroenterology. Liver. Pancreas. Abdomen
(41)
Pharmacology. Drug Treatments
(35)
Other Diseases. Semiology
(34)
Stomach. Duodenum. Small Intestine. Colon. Rectum. Anus
(33)
Crohn Disease - Drug Therapy
(32)
General & Internal Medicine
(31)
Inflammatory Bowel Disease
(31)
Biochemistry & Molecular Biology
(30)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Innate immune dysfunction in inflammatory bowel disease

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management

Probiotic lactobacilli and VSL#3 induce enterocyte β-defensin 2

European evidence based consensus on the diagnosis and management of Crohn’s disease: definitions and diagnosis

European evidence based consensus on the diagnosis and management of Crohn’s disease: current management

Short‐term efficacy of tacrolimus in steroid‐refractory ulcerative colitis – experience in 130 patients

NOD2 (CARD15) mutations in Crohn’s disease are associated with diminished mucosal α-defensin expression

European evidence-based Consensus on the management of ulcerative colitis: Current management

Infliximab as rescue medication for patients with severe ulcerative/indeterminate colitis refractory to tacrolimus

Long-term Outcomes in Steroid-refractory Ulcerative Colitis Treated with Tacrolimus Alone or in Combination with Purine Analogues

Steroid-unresponsive acute attacks of inflammatory bowel disease: immunomodulation by tacrolimus (FK506)

ABCB1 Single‐Nucleotide Polymorphisms Determine Tacrolimus Response in Patients With Ulcerative Colitis

Influence of standard treatment on ileal and colonic antimicrobial defensin expression in active Crohn’s disease

Defensin pattern in chronic gastritis: HBD-2 is differentially expressed with respect to Helicobacter pylori status

Randomized, double blind controlled trial of subcutaneous recombinant human interleukin-11 Versus prednisolone in active crohn's disease

European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease

European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis

Paneth cell α-defensin 6 (HD-6) is an antimicrobial peptide

Decreased Paneth cell defensin expression in ileal Crohn’s disease is independent of inflammation, but linked to the NOD2 1007fs genotype

6‐Thioguanine — efficacy and safety in chronic active Crohn's disease

Barrier dysfunction due to distinct defensin deficiencies in small intestinal and colonic Crohn's disease

Synergistic Sedation with Low-Dose Midazolam and Propofol for Colonoscopies

Alterations in pulmonary function in inflammatory bowel disease are frequent and persist during remission

Mycophenolate mofetil: lack of efficacy in chronic active inflammatory bowel disease

Innate immunity and colonic inflammation: Enhanced expression of epithelial α-defensins

Suchergebnisse filtern